Bangladesh now has a total of 129,818 doses of Covishield vaccine in stock, after administering some 10,070,182 doses since the start of the coronavirus vaccination program in the country.
The health authorities unveiled the information in a press release on Sunday.
Till now, Bangladesh has received 10.2 million Covishield doses from the Serum Institute of India (SII).
According to the press release, a little over 4.25 million people have received both doses, and a little over 1.57 million have received just the first dose.
Of those who received the first dose of the vaccine, 3,609,065 were men and 2,210,950 were women.
Meanwhile, 2,714,837 males and 1,535,330 females received the second dose.
According to the Directorate General of Health Services (DGHS), nearly 7.25 million people have registered for vaccination in the country till 5:30pm on Sunday.
The country on Sunday recorded 47 deaths from Covid-19, the highest single-day death toll reported in more than a month. It also registered 2,436 new cases.
Bangladesh started a pilot vaccination program on January 27 and the nationwide program on February 7 by administering Covishield, the Oxford-AstraZeneca Covid-19 vaccine manufactured by the SII.
Also Read - Covid-19: 2nd batch of 600,000 Sinopharm vaccine reach Dhaka
However, on April 25, the government suspended administering the first dose of the vaccine, just a day after India stopped exporting the vaccine due to the record-breaking surge in cases and deaths there.
As the SII could not provide the doses of vaccine, a good number of people around Bangladesh are still waiting for their second jabs.
However, on June 1, Bangladesh received the first consignment of 100,620 doses of the Pfizer-BioNTech Covid-19 vaccine, under the Covax scheme run by WHO and Gavi, the Vaccine Alliance.
Meanwhile, China has so far gifted 1.1 million Sinopharm vaccine doses to Bangladesh.
Bangladesh started giving the Sinopharm vaccine to medical college students last on June 1.
The Health Services Division will also procure a total of 15 million Sinopharm shots in the next three months – June, July and August.
The country is also negotiating with Russia to buy their Sputnik V vaccine and approved CoronaVac, the Covid-19 vaccine produced by Chinese company Sinovac Biotech.
